Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on AMG 0. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel L-alanine catalyzed route improves yield and purity for KRAS G12C inhibitor intermediates, offering cost-effective scale-up solutions.
Patent CN114907259A details a novel one-step hydrolysis and safer urea coupling route for Sotorasib intermediates, offering significant cost and safety advantages.